Free Trial
NASDAQ:KLTO

Klotho Neurosciences (KLTO) Stock Price, News & Analysis

Klotho Neurosciences logo
$0.21 +0.02 (+9.20%)
As of 04:00 PM Eastern

About Klotho Neurosciences Stock (NASDAQ:KLTO)

Key Stats

Today's Range
$0.19
$0.23
50-Day Range
$0.13
$0.29
52-Week Range
$0.11
$8.11
Volume
4.55 million shs
Average Volume
7.34 million shs
Market Capitalization
$6.82 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Klotho Neurosciences, Inc., a biopharmaceutical company, develops therapies for neurological and age-related disorders, and specialty diagnostics. Its products include cell and gene therapies to mitigate age-related pathologies, such as dementia symptoms, and Alzheimer and neuromuscular diseases; biologics/biosimilars in the treatment of cancer; and melanocortin receptors. The company has a strategic partnership with Japan's Okinawa Research Center for the research and development of Klotho gene therapy in enhancing longevity and reducing age-related diseases. The company was formerly known as Anew Medical, Inc. and changed its name to Klotho Neurosciences, Inc. in September 2024. Klotho Neurosciences, Inc. is based in Omaha, Nebraska.

Receive KLTO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Klotho Neurosciences and its competitors with MarketBeat's FREE daily newsletter.

KLTO Stock News Headlines

Head-To-Head Review: Klotho Neurosciences (KLTO) versus Its Rivals
Volatility Is Rising—But These 2 AI Stocks Could Thrive
2025 is off to a turbulent start—markets are swinging wildly, inflation pressures remain high, and recession fears are creeping back into headlines. But even in uncertain times, innovation doesn’t slow down. In fact, artificial intelligence (AI) is accelerating faster than ever—creating new profit opportunities while the broader market struggles. Our latest research reveals two AI stocks trading under $15 that could thrive even as volatility grows. These under-the-radar companies are positioned to ride the next wave of AI-driven demand—and they’re still flying below most investors’ radar.
Klotho Neurosciences faces Nasdaq delisting risk
Klotho Neurosciences, Inc. (KLTO)
See More Headlines

KLTO Stock Analysis - Frequently Asked Questions

Klotho Neurosciences' stock was trading at $0.4850 at the start of the year. Since then, KLTO stock has decreased by 56.7% and is now trading at $0.21.
View the best growth stocks for 2025 here
.

Klotho Neurosciences, Inc. (NASDAQ:KLTO) issued its earnings results on Thursday, May, 15th. The company reported ($0.08) earnings per share for the quarter.

Shares of KLTO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
5/15/2025
Today
5/27/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biological products, except diagnostic
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:KLTO
Previous Symbol
NASDAQ:KLTO
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$1.35 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Cash Flow
$0.22 per share
Price / Cash Flow
0.95
Book Value
($2.16) per share
Price / Book
-0.10

Miscellaneous

Free Float
26,539,000
Market Cap
$6.75 million
Optionable
N/A
Beta
-1.10
5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

This page (NASDAQ:KLTO) was last updated on 5/27/2025 by MarketBeat.com Staff
From Our Partners